Clinical Trial Update: Phase 2 Study of Gemzar, Taxol & Avastin Combination as 1st Line Treatment for Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of gemcitabine, paclitaxel, and bevacizumab as first-line therapy for metastatic breast cancer has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Gemzar (gemcitabine)
• Taxol (paclitaxel)

Snippet

Sponsor: George Albert Fisher | Conditions: Breast Cancer, Metastatic Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-03-24